Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning.

Precision oncology involves effectively selecting drugs for cancer patients and planning an effective treatment regimen. However, for Molecular targeted drug, using genomic state of the drug target to select drugs has limitations. Many patients who could benefit from molecularly targeted drugs, but they are being missed due to the insufficient labelling ability of the existing target genes. For non-specific chemotherapy drugs, most of the first-line anticancer drugs do not have biomarkers to guide doctor make treatment regimen. Furthermore, it is important to determine a long-term treatment plan based on the patient's genomic data during tumor evolution. Therefore, it is necessary to establish a tumor drug sensitivity prediction model, which can assist doctors in designing a personalized tumor treatment regimen. This paper proposed a novel model to predict tumor drug sensitivity including targeted drugs and non-specific chemotherapy drugs. This model uses statistical methods based on Bimodal distribution to select multimodal genetic data to solve dimensional challenges and reduce noise and to establish a classification model to predict the effectiveness of the drug in the tumor cell line using machine learning. The experimental test 87 molecular targeted drugs and non-specific chemotherapy drugs. The results show that the method can effectively predict the sensitivity of tumor drugs with an average sensitivity of 0.98 and specificity of 0.97. This model is worth to promotion. If it can be successfully used in clinical trials, it will effectively assist doctors to develop personalized cancer treatment programs and expand the application of molecularly targeted drugs.

Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning.

Blood-Brain-Barrier (BBB) is a strict permeability barrier for maintaining the Central Nervous System (CNS) homeostasis. One of the most important conditions to judge a CNS drug is to figure out whether it has BBB permeability or not. In the past 20 years, the existing prediction approaches are usually based on the data of the physical characteristics and chemical structure of drugs. However, these methods are usually only applicable to small molecule compounds based on passive diffusion through BBB. To deal this problem, one of the most famous methods is multi-core SVM method, which is based on clinical phenotypes about Drug Side Effects and Drug Indications to predict drug penetration of BBB. This paper proposed a Deep Learning method to predict the Blood-Brain-Barrier permeability based on the clinical phenotypes data. The validation result on three datasets proved that Deep Learning method achieves better performance than the other existing methods. The average accuracy of our method reaches 0.97, AUC reaches 0.98, and the F1 score is 0.92. The results proved that Deep Learning methods can significantly improve the prediction accuracy of drug BBB permeability and it can help researchers to reduce clinical trials and find new CNS drugs.

A Feature Extraction Method Based on Differential Entropy and Linear Discriminant Analysis for Emotion Recognition.

Feature extraction of electroencephalography (EEG) signals plays a significant role in the wearable computing field. Due to the practical applications of EEG emotion calculation, researchers often use edge calculation to reduce data transmission times, however, as EEG involves a large amount of data, determining how to effectively extract features and reduce the amount of calculation is still the focus of abundant research. Researchers have proposed many EEG feature extraction methods. However, these methods have problems such as high time complexity and insufficient precision. The main purpose of this paper is to introduce an innovative method for obtaining reliable distinguishing features from EEG signals. This feature extraction method combines differential entropy with Linear Discriminant Analysis (LDA) that can be applied in feature extraction of emotional EEG signals. We use a three-category sentiment EEG dataset to conduct experiments. The experimental results show that the proposed feature extraction method can significantly improve the performance of the EEG classification: Compared with the result of the original dataset, the average accuracy increases by 68%, which is 7% higher than the result obtained when only using differential entropy in feature extraction. The total execution time shows that the proposed method has a lower time complexity.